Fraud Suits Targeting Sanofi Over MS Drug Prospects Tossed
A Manhattan federal judge on Tuesday threw out an investor class action and a related securities fraud damages suit against Sanofi over a 2013 setback in its effort alongside recently acquired...To view the full article, register now.
Already a subscriber? Click here to view full article